Study #2022-0601
Circulating tumor material as a surrogate biomarker for radiotherapy treatment response in non-metastatic breast cancer: A prospective cohort study.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Circulating tumor material as a biomarker for radiotherapy TX response in breast cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Breast
Study phase:
Not applicable
Physician name:
Chelain Goodman
Department:
Radiation Oncology
For general questions about clinical trials:
1-866-967-2182
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.